Clinical Trials
4 trialsNCT04557449 2025-10-01
CDK4i
Pfizer
Phase 2 Active not recruiting
NCT00217464 2015-04-16
Fulvestrant in Treating Patients With Recurrent Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00476645 2014-08-05
Fulvestrant in Hormone Refractory Prostate Cancer
Stanford University
Phase 2 Completed
NCT00244998 2013-03-08
Fulvestrant in Treating Patients With Advanced Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Completed